Korro Bio, Inc.KRRONASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +62.67% | +11.28% | +17.02% | +4.50% | +0.95% |
| Weighted Average Shares Diluted Growth | +62.66% | +11.28% | +17.02% | +4.50% | +0.95% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | -91.80% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +154.14% | +2.06% | +2.13% | -27.71% | -33.67% |
| Book Value per Share Growth | +96.96% | -15.16% | -21.54% | -44.39% | -45.39% |
| Debt Growth | +33.84% | +34.81% | +25.81% | +16.04% | +6.90% |
| R&D Expense Growth | +21.97% | +9.99% | +45.44% | +22.72% | -13.43% |
| SG&A Expenses Growth | +98.52% | -41.80% | -26.75% | +4.69% | -36.23% |